Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Revenue | $128.0M | $144.0M | $74.3M | $1.2M | $305.0K | $4.0K |
| Cost of revenue | $92.1M | $100.5M | $93.4M | $0 | $0 | $0 |
| Gross profit | $35.9M | $43.5M | −$19.1M | $1.2M | $305.0K | $4.0K |
| Gross margin | 28.1% | 30.2% | -25.7% | 100.0% | 100.0% | 100.0% |
| R&D | $48.7M | $63.4M | $47.7M | $45.8M | $24.0M | $29.8M |
| Operating income | −$114.2M | −$140.1M | −$107.6M | −$117.8M | −$61.8M | −$67.1M |
| EBITDA | −$110.2M | −$135.4M | −$106.2M | −$164.6M | −$37.4M | −$114.1M |
| Net income | −$129.1M | −$148.0M | −$192.5M | −$178.5M | −$38.2M | −$124.1M |
| Net margin | -100.9% | -102.8% | -259.1% | -14316.0% | -12510.5% | -3102875.0% |
| EPS (diluted) | -119.71 | -80.17 | -86.30 | -46.42 | -6.40 | -78.70 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $6M | $-3.32 | $-3.32–$-3.32 | 1 |
| 2027 | $6M | $-1.86 | $-1.86–$-1.86 | 1 |
| 2028 | $21M | $-1.27 | $-1.27–$-1.27 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds BIOR.
No tracked institution reports a position in BIOR as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-10-18 | 1-for-10reverse |
| 2023-01-03 | 1-for-25reverse |
No one on the platform has traded BIOR yet.
| $982212 |
| — |
| EVFMEvofem Biosciences, Inc. | $0.01 | +0.00% | $1M | — |
| HALBHalberd Corporation | $0.00 | +0.00% | $464288 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$BIOR Adi Mohanti told my sister to send bobs and vagene. Apparently she didn't but shes got loose morals so Im unsure.
View on StockTwits ↗$BIOR Adi mohanti is a liar & thief and his loser ass company couldn’t develop a product or make any f’ing money, so they stole it from investors & planned the whole bankruptcy scheme!
View on StockTwits ↗@VoxGeorge nice bro! Yeah, I hit big on $AMC and the truth social stock, I think DWAC? And lost it all on PROG $BIOR
View on StockTwits ↗$BIOR 25k watchers!!! On this pos. Sure!!! Criminal run enterprise led by a freaking liar. All should be have been prosecuted by doj including the board of directors
View on StockTwits ↗$BIOR does anyone know what happens to our shares when a company goes private. I had some shared in this POS for a long time I forgot about. Am UK based. Thanks
View on StockTwits ↗$BIOR AstraZeneca is one of the confirmed collaborators; the others are anonymous. Current Status After successfully completing the legal restructuring process, the company's CEO, Adi Mohanty, confirmed that Biora Therapeutics has emerged from bankruptcy and become a private company with a healthy balance sheet. The company is currently maintaining its operations with a sole focus on the technical and commercial advancement of its BioJet™ oral autoinjection platform.
View on StockTwits ↗$BIOR Yes, after completing its bankruptcy restructuring process, Biora Therapeutics ceased to be a publicly traded company and became a private company. Ownership of its patents, technologies, and operating assets was transferred to a new corporate entity registered as BT Bidco Inc. (which operates under the trade name Biora Therapeutics). The company's current owners are a group of its former secured creditors, who assumed full control after executing a credit offer and exchanging the company's debt for control of its assets in bankruptcy court. The majority investment funds that control the company are: Highbridge Capital Management LLC: A US hedge fund focused primarily on healthcare investments and equity arbitrage. Davidson Kempner Capital Management LP: A global institutional investment management firm. Context Capital Management LLC: A firm specializing in fixed income strategies and arbitrage.
View on StockTwits ↗$BIOR 🤦🏽🤦🏽🤦🏽🤦🏽🤦🏽🤦🏽🤦🏽🤦🏽🤦🏽 https://www.biospace.com/press-releases/biora-therapeutics-advances-biojet-swallowable-autoinjector
View on StockTwits ↗$BIOR people lost everything here!! Thanks to liars & criminals
View on StockTwits ↗If you missed the deadline, don’t miss this update. You may still be able to recover losses from $BIOR — late claims are currently being accepted: https://11th.com/cases/progenity-investor-settlement This recovery fund was established after claims that Progenity misled investors about overbilling issues and financial risks ahead of its IPO. Even though the official deadline has passed, the court is still accepting late submissions. Who can apply? If you bought or held $BIOR between June 18, 2020, and December 2, 2020, you’re eligible — even if you already sold your shares
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.